DE60026491D1 - Melagatran zur behandlung von entzündungen - Google Patents

Melagatran zur behandlung von entzündungen

Info

Publication number
DE60026491D1
DE60026491D1 DE60026491T DE60026491T DE60026491D1 DE 60026491 D1 DE60026491 D1 DE 60026491D1 DE 60026491 T DE60026491 T DE 60026491T DE 60026491 T DE60026491 T DE 60026491T DE 60026491 D1 DE60026491 D1 DE 60026491D1
Authority
DE
Germany
Prior art keywords
melagatran
inflammation
treatment
prodrug
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60026491T
Other languages
English (en)
Other versions
DE60026491T2 (de
Inventor
Ian Kirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE60026491D1 publication Critical patent/DE60026491D1/de
Publication of DE60026491T2 publication Critical patent/DE60026491T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
DE60026491T 1999-01-13 2000-01-13 Melagatran zur behandlung von entzündungen Expired - Lifetime DE60026491T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9900070A SE9900070D0 (sv) 1999-01-13 1999-01-13 New use
SE9900070 1999-01-13
PCT/SE2000/000051 WO2000041716A1 (en) 1999-01-13 2000-01-13 New use of melagatran

Publications (2)

Publication Number Publication Date
DE60026491D1 true DE60026491D1 (de) 2006-05-04
DE60026491T2 DE60026491T2 (de) 2006-11-02

Family

ID=20414074

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60026491T Expired - Lifetime DE60026491T2 (de) 1999-01-13 2000-01-13 Melagatran zur behandlung von entzündungen

Country Status (20)

Country Link
US (3) US6683054B1 (de)
EP (1) EP1150704B1 (de)
JP (1) JP2002534477A (de)
KR (1) KR100701539B1 (de)
CN (1) CN1170592C (de)
AT (1) ATE319473T1 (de)
AU (1) AU767077B2 (de)
BR (1) BR0007452A (de)
CA (1) CA2356611A1 (de)
CY (1) CY1107465T1 (de)
DE (1) DE60026491T2 (de)
DK (1) DK1150704T3 (de)
ES (1) ES2257282T3 (de)
IL (1) IL143985A0 (de)
NO (1) NO20013414D0 (de)
NZ (1) NZ512713A (de)
PT (1) PT1150704E (de)
SE (1) SE9900070D0 (de)
WO (1) WO2000041716A1 (de)
ZA (1) ZA200105275B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
DE10133786A1 (de) * 2001-07-16 2003-02-06 Boehringer Ingelheim Pharma Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis
SE0103590D0 (sv) 2001-10-26 2001-10-26 Astrazeneca Ab New Combination
SE0200198D0 (sv) * 2002-01-23 2002-01-23 Astrazeneca Ab New use
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
KR20130053404A (ko) 2010-03-30 2013-05-23 베르선 코포레이션 트롬빈 억제제로서의 다중치환된 방향족 화합물
BR112015022340A2 (pt) 2013-03-15 2017-07-18 Verseon Corp método para tratamento ou prevenção de uma doença ou distúrbio relacionado à calicreína em um sujeito, composto, e, composição farmacêutica
US9951025B2 (en) 2013-03-15 2018-04-24 Verseon Corporation Halogenopyrazoles as inhibitors of thrombin
US10189810B2 (en) 2014-09-17 2019-01-29 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
ES2931460T3 (es) 2015-02-27 2022-12-29 Verseon Int Corporation Compuestos de pirazol sustituido como inhibidores de serina proteasa
US11865110B2 (en) 2018-07-13 2024-01-09 Verseon International Corporation Thrombin inhibitors, formulations, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
AR005245A1 (es) * 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
US5669754A (en) * 1996-04-22 1997-09-23 Advanced Dynamics Corporation Ltd. Method and apparatus for collecting plates
SE9601556D0 (sv) 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9603724D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New pharmaceutical parenteral formulation of a thrombin inhibitor
SE9802974D0 (sv) 1998-09-03 1998-09-03 Astra Ab New crystalline forms
WO2000018352A2 (en) 1998-09-28 2000-04-06 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
SE9900070D0 (sv) * 1999-01-13 1999-01-13 Astra Ab New use
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.

Also Published As

Publication number Publication date
JP2002534477A (ja) 2002-10-15
CN1170592C (zh) 2004-10-13
AU2336100A (en) 2000-08-01
KR20010101492A (ko) 2001-11-14
US20040082518A1 (en) 2004-04-29
CA2356611A1 (en) 2000-07-20
CY1107465T1 (el) 2012-12-19
KR100701539B1 (ko) 2007-03-30
US20080058303A1 (en) 2008-03-06
BR0007452A (pt) 2001-10-16
EP1150704B1 (de) 2006-03-08
NO20013414L (no) 2001-07-10
SE9900070D0 (sv) 1999-01-13
DE60026491T2 (de) 2006-11-02
AU767077B2 (en) 2003-10-30
ATE319473T1 (de) 2006-03-15
ES2257282T3 (es) 2006-08-01
IL143985A0 (en) 2002-04-21
CN1341028A (zh) 2002-03-20
US6683054B1 (en) 2004-01-27
EP1150704A1 (de) 2001-11-07
ZA200105275B (en) 2002-09-26
DK1150704T3 (da) 2006-06-12
NZ512713A (en) 2004-10-29
PT1150704E (pt) 2006-06-30
WO2000041716A1 (en) 2000-07-20
NO20013414D0 (no) 2001-07-10

Similar Documents

Publication Publication Date Title
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
JO2282B1 (en) Oxazole derivatives
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
SE9900961D0 (sv) Novel compounds
AR032293A1 (es) Estuche farmaceutico
SE9802208D0 (sv) Novel compounds
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
ATE360428T1 (de) Analgetisches arzneimittel
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
SE9802209D0 (sv) Novel compounds
NO20032006D0 (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
ATE350064T1 (de) Pharmazeutische zusammensetzungen von rapamycines
WO2006026604A3 (en) Methods for promoting wound healing
DE60009315D1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
SE0004827D0 (sv) Therapeutic compounds
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
SE0300535D0 (sv) Treatment of burns
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
SE0101762D0 (sv) New use
SE9900438D0 (sv) The pharmacological use of certian cystine derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition